The FinancialContent Network     SocialPicks Community   |   MarketMinute Monitor   |   MarketMinute Market Updates   |   MarketMinute Stock News
SocialPicks
   Sign Up   |   Log In   |   What is SocialPicks?     

 Putnam California Investment Grade Municipal Trust  (PCA) Trade Now »     Rate PCA  -  Discuss PCA  -  Add to Watch List         Graphic_subscribe

  
SocialPicks Sentiment:
N/A

** not enough data to be rated 		This Quarter's Sentiment:
All:
0.0%
Top:
0.0%
Rate PCA:


Home
Analysis & Videos
Quotes
Bull or Bear
Discuss
        

PCA: Bull or Bear? From:    SocialPicks  |  Blogsphere  |  All

SocialPicks Community



From the Blogosphere

Debunking the “Too Big To Fail” Myth

Washington’s Blog strives to provide real-time, well-researched and actionable information. George – the head writer at Washington’s Blog – is a busy professional and a former adjunct professor.

~~~

As MIT economics professor and former IMF chief economist Simon Johnson points out today, the official White House position is that:

<>

(1) The government created the mega-giants, and they are not the product of free market competition;

<>(2) The White House needs to “regulate and oversee them”, even though it is clear that the government has no real plans to regulate or oversee the banking behe<><><><><><><><>< /><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><>< /><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><>< /><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><>< /><><><><><><>< /><><><><><><>< /><><><><><><>< /><><><>< /><><><><><><>< /><><><><><><><><><><><><><><><><><><><><><><><><><><><><>< />< /><>< /><><>< /><>< /><>< /><>< /><>< /><>< /><>< /><>< /><>< /><>< /><>< />...
By  Barry Ritholtz   (+33.12%  risk: moderate)  10/14/09 Comment


We Can’t Break Up the Giant Banks, Can We? Yes We Can!

Washington’s Blog strives to provide real-time, well-researched and actionable information. George – the head writer at Washington’s Blog – is a busy professional and a former adjunct professor.

~~~

Top economists and financial experts believe that the economy cannot recover unless the big, insolvent banks are broken up in an orderly fashion.

Even the Bank of International Settlements – the “Central Banks’ Central Bank” – has slammed too big to fail. As summarized by the Financial Times:

<><>The report was particularly scathing in its assessment of governments’ attempts to clean<><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><>< /><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><>< />< /><>< /><><>< /><>< /><>< /><>< /><>< /><>< /><>< /><>< /><>< /><>< /><>< />...
By  Barry Ritholtz   (+33.12%  risk: moderate)  09/15/09 Comment


What is the Intent of Fair Value Accounting?

It looks like the FASB is in full retreat on fair value accounting.  Below is an artifact from the period we published today in The IRA.  Author is a very well respected analyst who worked for the Fed in the 2007 period and tried to sound a warning about the supervisory implications of a FVA regime.  I am going to do a victory lap at AEI today when we convene the latest “Deflating Bubble” session. – Chris

The Institutional Risk Analyst

March 17, 2009

<><>The following article on fair value accounting (”FVA”) was authored in May 2007 by a researcher who at the time w<><><><><><><><><><><><><><><><><><><><><><><><>< /><><><><><><><><><><><><><><><><><><><><><><><><><>< /><>< /><>< /><>< /><>< /><>< /><>< /><>< /><>< /><>< /><>< />...
By  Barry Ritholtz   (+33.12%  risk: moderate)  03/17/09 Comment


YM BioSciences: An Update From Collins Stewart Growth Conference Presentation
Logo1
38%
YM BioSciences (AMEX: YMI) 1-Year Chart
<>
The Chairman and CEO of Canadian biotech YM BioSciences (YMI), David Allan, presented yesterday at the Collins Stewart Fourth Annual Growth Conference, which provided investors with an overview and update on the prospects for the Company. YM Bio has two late-stage products in development, including the cancer drug nimotuzumab (nimo) and inhaled pain treatment AeroLEF. The stock closed today near all-time lows at 77 cents within a 52-week range of $0.70 - $1.89, resulting in a market cap of just $43 million (M) despite having no debt, a projected cash l...
By  StraightStocks   (-8.12%  risk: moderate)  07/09/08 Comment


YM BioSciences: An Update From Collins Stewart Growth Conference Presentation
Logo1
38%
YM BioSciences (AMEX: YMI) 1-Year Chart
<>
The Chairman and CEO of Canadian biotech YM BioSciences (YMI), David Allan, presented yesterday at the Collins Stewart Fourth Annual Growth Conference, which provided investors with an overview and update on the prospects for the Company. YM Bio has two late-stage products in development, including the cancer drug nimotuzumab (nimo) and inhaled pain treatment AeroLEF. The stock closed today near all-time lows at 77 cents within a 52-week range of $0.70 - $1.89, resulting in a market cap of just $43 million (M) despite having no debt, a projected cash l...
By  StraightStocks   (-8.12%  risk: moderate)  07/09/08 Comment



ROCK-STAR INVESTORS
Rank Name Sharpe Ratio Avg Return Followers
1 noshoes 21.10 +34.57% 370
2 Gerald Greene 18.14 +68.57% 207
3 stockmarketfunding.com 17.66 +25.68% 53
4 akiralegrand 13.47 +14.32% 61
5 anup2104 12.13 +77.15% 35


POPULAR STOCKS
Symbol Company Name Sentiment
PFE Pfizer Inc
DELL Dell Inc
FRE Freddie Mac
POT Potash Corp. of Saskatchewan Inc.
AIG American International Group Inc.
JPM JPMorgan Chase & Co

TODAY'S HEADLINES

TODAY'S TOP PICKS

 

StreetInsider.com on PCA

Visit streetinsider.com


Discussion Wall + Add  

Be the first to start a discussion and earn 2 points.



More Resources

Graphic_arrow1 About Putnam California Investment Grade Municipal Trust - Answers.com

Graphic_arrow1 Historical Prices - Yahoo

Graphic_arrow1 Message Boards - BoardCentral.com

Graphic_arrow1 More Info:     Yahoo   |   Google   |   Reuters




IN THE PRESS
Press_forbes Press_washingtonpost Press_wsj Press_npr Press_techcrunch